Cannabis
These results suggest that substitution of cannabis for traditional pain medications increases as the availability of recreational cannabis increases. There appears to be a small shift once recreational cannabis becomes legal, but we see stronger results once users can purchase cannabis at recreational dispensaries. The decrease in opioids and marginal increase in non-opioid pain medication may reflect patients substituting opioids with cannabis and non-opioid pain medications, either separately or concomitantly. Reductions in opioid prescription fills stemming from recreational cannabis legalization may prevent exposure to opioids in patients with pain and lead to decreases in the number of new opioid users, rates of opioid use disorder, and related harms.
Authors
- Hailemichael Shone
- Felipe Lozano-Rojas
- Shelby R. Steuart
- Amanda J. Abraham (ORCID: https://orcid.org/0000-0002-7455-7464)
- Victoria Bethel
Institutions
- University of Georgia (US)
- University of Chicago (US)
- Indiana University Bloomington (US)
Publication Details
- Journal
- Cannabis
- Published
- 2024-10-18
- DOI
- https://doi.org/10.26828/cannabis/2024/000268
- Citations
- 1
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- National Institutes of Health
- National Institute on Drug Abuse